Atrion Corp (NASDAQ:ATRI)

CAPS Rating: 4 out of 5

The Company designs, develops, manufactures, sells and distributes products and components for the medical and healthcare industry.

Recs

1
Player Avatar dcrednek (79.52) Submitted: 1/5/2007 9:22:41 AM : Outperform Start Price: $77.27 ATRI Score: +105.52

ATRI, a medical products company in Bethesda, is a nice play in undervalued, micro-cap sector. The management team has done and continues to do a great job of building the company, both top line and bottom. Estimates for 07 put the company at $0 debt and about $6/share in earnings. ATRI's annualized growth rate tops 15%, so it's a buy at a P/E of 13. Definitely an OUTPERFORM

Report this Post Reply

Featured Broker Partners


Advertisement